For EpCAM-dependent breast cancer invasion, the transcription factor AP-1 was reported to participate in the MEKK1/MKK7/JNK pathway, while EpCAM was shown to modulate the effects of NF-κB and IL-8 during BC progression [73]. This evidence concerns the gene NFKB1 and breast cancer.